REBECCA RUMMEL: Open Payments
NPI 1134593676 · OCEAN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$751 in 28 payments from 13 companies in 2025. Trend: 2023 $854 · 2024 $1,016 · 2025 $751
Food & beverage: $751
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $178 |
| AstraZeneca Pharmaceuticals LP | 2 | $141 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $90 |
| Philips North America LLC | 4 | $87 |
| PFIZER INC. | 3 | $44 |
| ABIOMED | 2 | $42 |
| Smith+Nephew, Inc. | 1 | $38 |
| United Therapeutics Corporation | 2 | $34 |
| Viatris Specialty LLC | 1 | $24 |
| Daxor Corporation | 1 | $19 |
Products named: NUCALA, TEZSPIRE, Vest Therapy Und, ELIQUIS, Pico 14, JASCAYD, YUPELRI, BVA-100.
Industry payments across NJ — which companies pay providers there.
